Kelley Shannon T
- SEC CIK
- 0002034056
In the past year, 3 open-market sale filings worth $841.6K and no purchases.
Current role at each company
- MDGL Madrigal Pharmaceuticals, Inc.General Counselas of Aug 20, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $841.6K
- 3 filings
- Net
- −$841.6K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Kelley Shannon T as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 20, 2026 (view filing)4:20 PM ET | Aug 17 | 3 daysLate | Kelley Shannon TGeneral Counsel | SSale | −664 | $514.97 | −$341.9K | −5.5%11.5K after | |
| Mar 6, 2026 (view filing) | Mar 6 | Same day | Kelley Shannon TGeneral Counsel | SSale | −360 | $431.94 | −$155.5K | −2.9%12.1K after | |
| Jan 20, 2026 (view filing) | Jan 20 | Same day | Kelley Shannon TGeneral Counsel | SSale | −692 | $497.36 | −$344.2K | −7.5%8.48K after | 2 lots10b5-1 |
| Aug 18, 2025 (view filing) | Aug 18 | Same day | Kelley Shannon TGeneral Counsel | SSale | −1.30K | $367.81 | −$479.6K | −12.4%9.17K after | 8 lots10b5-1 |
| Mar 5, 2025 (view filing) | Mar 3 | 2 days | Kelley Shannon TGeneral Counsel | SSale | −415 | $335.00 | −$139.0K | −5.4%7.29K after | 10b5-1 |
| Jan 17, 2025 (view filing) | Jan 17 | Same day | Kelley Shannon TGeneral Counsel | SSale | −277 | $273.41 | −$75.7K | −3.5%7.71K after |